Stocks and Investing
Stocks and Investing
Mon, November 7, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Matthew Akers Maintained (BAH) at Buy with Increased Target to $109 on, Nov 7th, 2022
Matthew Akers of Wells Fargo, Maintained "Booz Allen Hamilton Holding Corporation" (BAH) at Buy with Increased Target from $100 to $109 on, Nov 7th, 2022.
Matthew has made no other calls on BAH in the last 4 months.
There are 5 other peers that have a rating on BAH. Out of the 5 peers that are also analyzing BAH, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Tobey Sommer of "Truist Securities" Maintained at Hold with Increased Target to $106 on, Monday, October 31st, 2022
- Brian Gesuale of "Raymond James" Downgraded from Buy to Hold on, Wednesday, October 19th, 2022
These are the ratings of the 3 analyists that currently disagree with Matthew
- Cai Rumohr of "Cowen & Co." Maintained at Buy with Increased Target to $123 on, Monday, October 31st, 2022
- Bert Subin of "Stifel" Maintained at Strong Buy with Increased Target to $105 on, Tuesday, September 13th, 2022
- Matthew Sharpe of "Morgan Stanley" Maintained at Buy with Increased Target to $105 on, Tuesday, August 2nd, 2022
Contributing Sources